NEW YORK (GenomeWeb News) – Complete Genomics disclosed in a filing with the US Securities and Exchange Commission this week that another lawsuit has been field against the firm by a "purported stockholder" alleging a breach in fiduciary duties in connection with the firm's proposed $117.6 million merger with BGI. It is the latest in a handful of suits filed against Complete Genomics, its board of directors, and executives seeking to block the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.